Polaris Office announced on May 9, 2025, that it has been officially selected for 'Connect,' the partner program of NVIDIA, the global leader in artificial intelligence (AI) computing.
Through this partnership, Polaris Office will receive advanced technology support from NVIDIA for 'Askdoc for Pharma,' an AI model specialized in the pharmaceutical and biotech sectors, which is being co-developed with its group’s pharmaceutical affiliate, Polaris AI Pharma.
'Askdoc for Pharma' is an AI model under development for commercialization, designed to specialize in all aspects of pharmaceutical R&D, including analysis of academic papers and patents, compound searches, and summarization of drug mechanisms.
Building on this collaboration, Polaris Office plans to maximize the learning efficiency and inference performance of its AI model by actively utilizing NVIDIA's high-performance AI development resources and GPU-accelerated infrastructure together with Polaris AI Pharma.
NVIDIA’s Connect program is a global partnership platform that provides companies with AI capabilities a variety of benefits, including priority access to large-scale GPU clusters, model optimization workshops and technical consulting, and joint marketing and sales opportunities.
Lee Haeseok, Head of Business Division and Group Chief AI Officer (CAIO) at Polaris Office, stated, "Based on NVIDIA's high-performance computing capabilities and optimization technology, we will further enhance the precision and stability of Askdoc for Pharma." He emphasized, "Through collaboration with Polaris AI Pharma, we will maximize technological synergy at the group level and accelerate the commercialization of generative AI solutions optimized for specialized industries."
Meanwhile, the Polaris Office Group is actively pursuing joint growth across the group by implementing a 'vertical AI' strategy to apply AI throughout industries, centering on Polaris Office and its diverse affiliates such as Polaris Sewon, Polaris Uno, Polaris AI, and Polaris AI Pharma.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
